Bases Moleculares de la Arteriosclerosis
CTS347
Hospital Universitario Virgen de la Victoria
Málaga, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de la Victoria (7)
2020
-
Evaluation of the chylomicron-TG to VLDL-TG ratio for type I hyperlipoproteinemia diagnostic
European Journal of Clinical Investigation, Vol. 50, Núm. 12
2018
-
Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations
Journal of the American College of Cardiology, Vol. 72, Núm. 20, pp. 2471-2481
-
Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society
Journal of Clinical Lipidology, Vol. 12, Núm. 6, pp. 1482-1492.e3
2010
-
Cocientes lipoproteicos: significado fisiológico y utilidad clínica de los índices aterogénicos en prevención cardiovascular
Clinica e Investigacion en Arteriosclerosis, Vol. 22, Núm. 1, pp. 25-32
2009
-
Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention
Vascular Health and Risk Management
2007
-
Management of dyslipidemia in the metabolic syndrome: Recommendations of the Spanish HDL-forum
American Journal of Cardiovascular Drugs, Vol. 7, Núm. 1, pp. 39-58
2004
-
Significance of high density lipoprotein-cholesterol in cardiovascular risk prevention: Recommendations of HDL Forum
American Journal of Cardiovascular Drugs, Vol. 4, Núm. 5, pp. 299-314